Publisher’s Note: Psychoactives, a New Open Access Journal

Basel is sometimes referred to as the birthplace of hallucinogenic science, where in 1938 Albert Hofmann first discovered lysergic acid diethylamide (LSD) [1]. There has recently been a renewed interest in psychoactive substances, in terms of both their medical use and to better understand their toxicological effects. Following this tradition, MDPI is pleased to announce the launch of a new Basel-based journal: Psychoactives (ISSN 2813-1851) [2].

Psychoactives aims to bring together experts from across a broad field of research to cover the chemical, biological, neurological, medical, environmental, social, and political aspects of psychoactive drugs.

The journal’s scope will cover, but is not limited to, the following:

• Chemistry: Synthesis, structure–activity relationship, extraction and purification techniques, and analytical chemistry;
• Biology: Plant biology (for natural psychoactive substances);
• Pharmacy: Mode of action, receptor binding, metabolism, absorption and distribution, and toxicology;
• Medicine: Medicinal uses, clinical trials, clinical neurology, psychiatry, and addiction studies;
• Environmental sciences: Water contamination in addition to psychoactive substances and their impacts on ecosystems;
• Social and political: Opioid crisis, homelessness, incarceration, and legalization.

As with all of MDPI’s open access journals, we strive to provide excellent services as well as a fast and rigorous peer review process. Additionally, we would like to extend a warm welcome to all of our Editorial Board Members, and we hope that you will enjoy publishing with us.